The Global Metabolomics Services Market Size is valued at 573.6 Mn in 2023 and is predicted to reach 1441.73 Mn by the year 2031 at a 13.25% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The metabolomics services industry is driven by a variety of diagnostic biomarkers and cutting-edge methods for medication research and development.
- The metabolomics services market is expected to be motivated by the rising tide of cancer diagnoses worldwide, affecting various body parts.
- North America dominated the market and accounted for a revenue share of global revenue in 2023.
- The market's expansion will be impeded most severely by the high expense of R&D and problems with data inspection and processing.
Metabolomics is a comprehensive study of metabolites. The metabolites produced by the cell during metabolism are collectively called metabolomes. It is an analytical profiling technique for estimating and comparing vast numbers of metabolites in biological samples. Existing metabolomic technologies go well beyond the scope of standard clinical chemistry techniques and can precisely analyze hundreds to thousands of metabolites.
The human body has thousands of metabolites in the human metabolome, which are associated with genetic disorders. This metabolome profiling can assist in a better understanding of diseases and helps to identify new biomarkers for diagnosis and prognosis.
The metabolomics technique can potentially improve the efficacy and rate of drug discovery by employing metabolite detection techniques that comprise identification, quantification, and targeted and untargeted metabolomic profiling. With the help of metabolomics, it is possible to explore the products obtained during metabolic conversions by gut microbiota from dietary components and examine what kind of metabolic alterations they evoke in the circulation and potential target tissues.
Key Developments in the market:
- In Apr 2022, Creative Proteomics Metabolomics Launched its Animal Untargeted Metabolomics Solutions for Scientific Research. This untargeted metabolomic profiling is based on chromatographic technique and spectrometry platform. It will help in early-stage diagnosis and discover novel biomarkers, potentially leading to new insights into disease mechanisms or treatment.
- In Mar 2021, IFF (formerly DuPont Nutrition & Biosciences) researchers, in collaboration with researchers from Afekta Technologies Ltd., and the University of Oulu, had released the findings of their study on the health effects of Litesse® polydextrose, a soluble fibre with prebiotic properties. Metabolomic analytics can examine and identify the metabolites produced by gut microbiota in food and nutrition research.
Competitive Landscape:
Some of the Metabolomics Services Market players are:
- Biocrates life sciences ag
- Creative Proteomics
- DNA Xperts
- Eremid Research Services
- Human Metabolome Technologies (HMT)
- Metabo Profile
- Metabolon
- MS-Omics
- Novelgene Technologies
- Synbio Technologies
- Afekta Technologies Ltd.
- BASF SE
- Chenomx Inc.
- The Metabolomics Innovation Centre (TMIC)
- Lipotype GmbH
- Metasysx GmbH
- Other Prominent Players
Market Segmentation:
The global metabolomics services market is segmented by Type of Technique, Type of Service, applications, and end-user. LC-MS, GC-MS, and NMR are the types of the technique. In comparison, Targeted and untargeted metabolomics are types of the services. By application, the metabolomics services market is divided into biomarker discovery, personalized medicine, disease diagnosis, drug discovery and toxicological testing, which are responsible for overall industry growth. The end-users of the market are research and academic institutes, pharma and biotech firms and CROs. These end-users provide the need for metabolome profiling due to the research advancements.
Market Dynamics:
The diverse need for biomarkers for diagnosis and advanced techniques for drug development & discovery will propel the metabolomics services market. Recognition of chronic diseases with the metabolomic separation method allows healthcare providers to provide effective disease treatment. Rising awareness of the usage of metabolomics techniques among drug developers and application industries as it has more pros and fewer cons.
Moreover, Pharmaceutical companies are raising funds and increasing collaborations with other specialty companies for research, and expanding diagnosing facilities will boost the market growth. The method is cost-effective in the study. In Apr 2022, Creative Proteomics Metabolomics Launched Animal Untargeted Metabolomics Solutions for Scientific Research. This untargeted metabolomic profiling is based on a chromatographic technique and spectrometry platform.
Market Challenges:
However, increasing the cost of analyzing instruments and maintenance will hamper the services market. Delayed funding, process time and availability of experts will slow down the market growth.
Regional Outlook:
North America will lead the market with substantial investments and more facilities for analyzing the product or materials. It is followed by Europe with different collaborations and partnerships for the developments.
Metabolomics Services Market Report Scope:
|
Report Attribute |
Specifications |
|
Market size value in 2023 |
USD 537.6 Mn |
|
Revenue forecast in 2031 |
USD 1441.7 Mn |
|
Growth rate CAGR |
CAGR of 13.25% from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Million, and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Type Of Technique, Type Of Service, Applications, And End-User |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Biocrates life sciences ag, Creative Proteomics, DNA Xperts, Eremid Research Services, Human Metabolome Technologies (HMT), Metabo Profile, Metabolon, MS-Omics, Novelgene Technologies, Synbio Technologies, Afekta Technologies Ltd., BASF SE, Chenomx Inc., The Metabolomics Innovation Centre (TMIC), Lipotype GmbH, Metasysx GmbH |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
